Xpert® Xpress SARS-CoV-2
Cepheid has developed an automated molecular test for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19. The test leverages the design principles of our current Xpert® Xpress Flu/RSV cartridge technology, in which multiple regions of the viral genome are targeted. The test can provide rapid detection of the current pandemic coronavirus SARS-CoV-2 in approximately 45 minutes with less than a minute of hands on time to prepare the sample.
Xpert® Xpress SARS-CoV-2 can be utilized in multiple settings where actionable test results are needed to make informed treatment decisions quickly. The test delivers point-of-care results with the same level of performance seen in reference labs. The test is designed for use on Cepheid’s GeneXpert® Systems, which have a worldwide footprint of more than 23,000 placements.
Pricing is quoted per project. Tell us your volumes and destination and we will send availability and a quotation.
About the Xpert® Xpress SARS-CoV-2
Cepheid has developed an automated molecular test for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19.
Ryvex supplies the Xpert® Xpress SARS-CoV-2 to laboratories in the Caribbean and Latin America. Product availability and registration can vary by country — ask us about your market.
Related products
More from Cepheid
Request a quote
Interested in the Xpert® Xpress SARS-CoV-2?
Send us the instruments, reagents or controls you are looking for. Our team replies with availability, lead times and a quotation.
- Sales
- +1 305 592 1233
- [email protected]